Clinical Trial: Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: Phase IV, Open-label, Multi-center, Single-arm Study of the Safety and Efficacy of Everolimus (Afinitor) in Adult Patients With Local Advanced or Metastatic, Well Differentiated Progressive Pancreatic

Brief Summary: To evaluate safety and efficacy of everolimus (Afinitor®) in Chinese adult patients with local advanced or metastatic, well differentiated progressive pancreatic neuroendocrine tumors.